Previous Close | 37.58 |
Open | 37.59 |
Bid | 38.45 x 1000 |
Ask | 38.59 x 1300 |
Day's Range | 37.52 - 38.33 |
52 Week Range | 37.35 - 80.72 |
Volume | |
Avg. Volume | 6,232,579 |
Market Cap | 19.252B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 18.45 |
EPS (TTM) | 2.07 |
Earnings Date | Apr 27, 2023 |
Forward Dividend & Yield | 1.16 (2.54%) |
Ex-Dividend Date | Dec 01, 2022 |
1y Target Est | 54.37 |
(Reuters) -U.S. scientific instruments maker Thermo Fisher Scientific Inc and South Korea's Celltrion Inc are among those competing to acquire the biopharma solutions business of medical device maker Baxter International Inc, according to people familiar with the matter. The divestment, which the sources said could fetch more than $4 billion, would help Baxter pay down debt following its $10.5 billion acquisition of medical device maker Hill-Rom Holdings in 2021. Private equity firms, including KKR & Co and Carlyle Group, have also expressed interest in the Baxter business, the sources said.
In this article, we will look at the 14 best falling stocks to buy now. If you want to explore similar stocks, you can also take a look at 5 Best Falling Stocks To Buy Now. The next FOMC meeting is just around the corner. With the jobs report and the much awaited CPI report, we now have […]
In this article, we will discuss the 15 best 52-week low stocks to buy now. If you want to explore similar stocks, you can also take a look at 5 Best 52-Week Low Stocks To Buy Now. 2022 was terrible for the equities market, as inflation reached new highs and took interest rates with it. […]